Re: Zenith Capital Corp. to Present on the Emerging Growth Conference on September 25, 2024
posted on
Sep 25, 2024 04:04PM
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
guess these folks below didn't see your memo - the more u flap the more you sound like mccafray- take a break , you'd swear u we're 20 -30 years old & have another 20-30 years to wait on this clown to accomplish something significant!
13 million for both company's to move the science forward & u give donnys plan moving forward an 8 out of ten. Delusional imho.
Below is what Don accomplished today with his rose colored glasses. What flop! This is where we're at? What "discussion" has he been in & with & who. Reaching out for bread crumbs like a cornered rat imo.
DATE
|
TIMESTAMP
|
PRICE
|
VOLUME
|
---|---|---|---|
09/25/2024 | 12:03:01 |
0.000001
|
7,680 |